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Macrophages are terminally diﬀerentiated cells of the mononuclear phagocytic lineage and develop under the stimulus of their
primary growth and diﬀerentiation factor, CSF-1. Although they diﬀerentiate into heterogeneous populations, depending upon
theirtissueofresidence,motilityisanimportantaspectoftheirfunction.Tofacilitatetheirmigrationthroughtissues,macrophages
express a unique range of adhesion and cytoskeletal proteins. Notably, macrophages do not form large, stable adhesions or actin
stress ﬁbers but rely on small, short lived point contacts, focal complexes and podosomes for traction. Thus, macrophages are built
to respond rapidly to migratory stimuli. As well as triggering growth and diﬀerentiation, CSF-1 is also a chemokine that regulates
macrophage migration via activation the CSF-1 receptor tyrosine kinase. CSF-1R autophosphorylation of several intracellular
tyrosine residues leads to association and activation of many downstream signaling molecules. However, phosphorylation of just
oneresidue,Y721,mediatesassociationofPI3Kwiththereceptortoactivatethemajormotilitysignalingpathwaysinmacrophages.
Dissection of these pathways will identify drug targets for the inhibition of diseases in which macrophages contribute to adverse
outcomes.
1.Introduction
Macrophagesresideinalmosteverytissueofthebodyand,as
a result of their adaptation to the diﬀerent tissue microenvi-
ronments, adopt a diverse range of morphologies and carry
out a variety of functions. Despite their heterogeneity, ma-
crophages all originate from the pluripotent hematopoietic
stem cell and, under the inﬂuence of hematopoietic growth
factors, diﬀerentiate through several multipotent progenitor
stagestolineagecommittedmononuclearphagocyticprecur-
sors in the bone marrow[1–3]. The mononuclear phagocyte
system is comprised of the mononuclear phagocyte pre-
cursors, monoblasts, and promonocytes, as well as circu-
lating monocytes and fully diﬀerentiated, tissue resident ma-
crophages [1–4]. Colony-stimulating factor-1 (CSF-1) has
longbeenrecognizedastheprimarygrowthfactorregulating
the survival, proliferation, and diﬀerentiation of cells of the
mononuclear phagocytic lineage [1, 3, 5]. It is also an essen-
tial diﬀerentiation factor for the bone resorbing osteoclast
[6]. A spontaneously occurring inactivating mutation in the
mouse CSF-1 gene (osteopetrotic, Csf-1op) is associated with
reducedtissuemacrophagenumbersandamarkedreduction
in osteoclasts, and causes osteopetrosis along with other
developmental defects [1, 7–9]. CSF-1 signals through the
CSF-1 receptor tyrosine kinase (RTK), encoded by the c-fms
proto-oncogene [10], to trigger a series of phosphorylation
cascades that mediate cellular responses to CSF-1 [1]. While
the phenotype of mice nullizygous for the CSF-1R (Csf1r−/
Csf1r−) largely recapitulates that seen in the Csf1op/Csf1op
mouse, it is more severe and the discrepancy has since been
explained by the discovery of a second partially redundant
ligand for the CSF-1R, interleukin-34 (IL-34) [11–13].
Macrophagesareprofessionallymotilecellsthatcarryout
a variety of roles in immune surveillance and normal tissue
development by secreting cytokines and growth factors and
phagocytosing foreign material and apoptotic cells. Tran-
sendothelial and interstitial motility is an essential aspect
of their function as they must be able to move to speciﬁc
sites upon demand. From studies in primary macrophages
and CSF-1 dependent macrophage cell lines, it is evident
that CSF-1 is not only a mononuclear phagocyte lineage
growth factor but is an important regulator of macrophage2 International Journal of Cell Biology
motility [1, 14–16]. Depletion of speciﬁc subsets of tissue
macrophages in the Csf1op/Csf1op mouse and their reconsti-
tution upon restoration of CSF-1 expression indicates that
CSF-1 regulates the diﬀerentiation and migration of trophic
and/or scavenger macrophages that are physiologically
important for normal development and tissue homeostasis
rather than in immune function [3, 9, 11, 17]. CSF-1
or CSF-1R deﬁcient mice demonstrate abnormal neural,
skeletal,andglandulardevelopment,notonlyduetoreduced
macrophage and osteoclast numbers but also through
reduced matrix remodeling [3]. Thus, CSF-1-induced motil-
ity is likely to be an important element of macrophage func-
tion in development. Beyond their critical physiological role,
CSF-1 dependent macrophages have also been demonstrated
to promote disease progression in conditions ranging from
cancer to atherosclerosis and arthritis [1, 3, 18, 19]. Re-
activation of developmental macrophage functions may
underlie the progression of these pathologies [3]. To partic-
ipate in the disease process, macrophages must ﬁrst migrate
to the aﬀected tissue. Furthermore, in the case of enhance-
ment of tumor invasion, tumor-associated macrophages and
mammary carcinoma cells have been shown to migrate away
from the primary tumor together [20]. Yet little is known
about how macrophage motility is regulated, how the mo-
tility machinery diﬀers from other cell types and whether
inhibition of macrophage motility may improve disease out-
comes. Moreover, CSF-1 activated signaling pathways acti-
vate molecules or protein isoforms selectively expressed in
macrophages [1], some of which may be attractive ther-
apeutic targets to speciﬁcally inhibit macrophage inﬁltra-
tion into sites of disease. Considering the contribution of
macrophages and CSF-1 to tumour dissemination and the
progression of several inﬂammatory disorders [3, 18, 19],
this review focuses on our current understanding of macro-
phage migration and its regulation by CSF-1.
2. Macrophage Motility
Almostallcelltypesarecapableofmigrationbut,intheadult
organism, motility is particularly important for cells partic-
ipating in immune cell function and wound healing. Leuko-
cytes move rapidly compared to other cells, with neutrophils
and lymphocytes measured at speeds of up to 25–30μm/min
[21, 22]. While macrophages are slower than other leuko-
cytes, moving at ∼1μm/min in vitro, in vivo they respond
rapidly to wounding or inﬂammatory signals and can mi-
grate over considerable distances. Indeed, their migration
speed has been measured at over 10μm/min when attracted
into a wound in a ﬁsh model [23]. Compared to ﬁbroblasts
and epithelial cells (∼0.1–0.5μm/min) [21], macrophages
are considered to be eﬃcient migrators.
The fundamental locomotory mechanisms are broadly
similar in most cell types [24, 25]. Motility is a complex and
integrated process that has typically been broken down into
ﬁve components: (1) cell polarization or breaking of symme-
try upon designation of the leading edge, (2) actin polym-
erization-driven protrusion of the leading edge, (3) integrin-
mediated adhesion of the extended protrusion to underlying
extracellular matrix proteins to provide the necessary trac-
tion for (4) actomyosin contractility-based forward translo-
cation of the cell body, and, ﬁnally, (5) de-adhesion of the
trailing edge to complete the cycle [25, 26]. Nevertheless, this
description is a simpliﬁcation of an integrated process, for
example actin polymerization and actomyosin contraction
contribute to adhesion structure formation and maturation
atthefrontofthecellandtotheirdisassemblyattherear[27,
28] and adhesion strength aﬀects protrusion and migration
[29]. Furthermore, these processes most accurately describe
a style of locomotion employed by mesenchymal cells such
as ﬁbroblasts and by endothelial cells. Leukocytes more
commonly use a migration mode typiﬁed by the amoeba,
Dictyosteliumdiscoides[22].Thediﬀerencesinamoeboidand
mesenchymal migration are most clearly seen in 3D matrix
environments where the interstitial matrix is preserved rath-
er than digested and migrating cells do not appear to adhere
to the matrix proteins in amoeboid migration [21, 22].
Indeed, recent work indicates that integrins are not required
for interstitial migration of dendritic cells in the dermis or
lymph nodes but are indispensable for transendothelial
migration [30, 31]. Consistent with their intermediate mi-
gration speed, macrophages appear capable of both amoe-
boid and mesenchymal interstitial migration, depending on
the structure and density of the surrounding matrix, as they
can either propel themselves through loose connective tissue
or actively digest a path through denser interstitial matrix
[32, 33]. Moreover, matrix remodeling by tumor-associated
macrophagespromotesbreastcancercellinvasion,indicating
that macrophages normally digest extracellular matrix dur-
ing interstitial migration [34].
Examination in vitro of the actin cytoskeleton and
adhesion structures in macrophages and ﬁbroblasts indicates
important mechanistic diﬀerences in the motility machinery
between the two cell types (Figure 1). As the leading edge
of a ﬁbroblast extends, it forms small nascent adhesions
(Figures 1(a) and 1(c), yellow) that either quickly disappear
or, if they are connected to actin microﬁlaments, cluster
into small focal complexes just behind the leading edge
(Figures 1(a), arrow; and 1(c), green). Then, as the ﬁbroblast
continues to move forward, the focal complexes in their turn
eitherdisappearormatureandcoalesceintolargerfocalcon-
tacts(1–5μM)thatanchorthickactinbundlesorstressﬁbers
(Figures 1(a), arrowhead; 1(c), red) [25, 35–37]. Indeed, the
thickness of the bundled actin appears to control the size
and shape of the underlying adhesion [36, 37]. In contrast
to ﬁbroblasts, macrophages form innumerable dot-like point
contacts of varying phosphopaxillin content (Figures 1(b)
and 1(d), yellow and red) under the ventral surface, most
strikingly in the leading lamellipodium, along with scattered,
mostly peripherally located focal complexes (Figure 1(d),
green). Point contacts are also found in neuronal growth
cones and highly motile cells [38] and resemble the widely
distributed nascent adhesions of spreading ﬁbroblasts after
replating [39]. Macrophage adhesions do not mature into
largefocalcontactswithattachedstressﬁbers,althoughsome
focal complexes do anchor thin actin bundles (Figure 1(b),
arrow) [16, 40]. Inverted phosphopaxillin immunoﬂuo-
rescent images clearly demonstrate the strikingly diﬀerentInternational Journal of Cell Biology 3
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Figure 1: Macrophages are built for rapidly responsive migration. (a) A primary ﬁbroblast, grown on a ﬁbronectin coated coverslip in
α+MEM, 10% FCS, and 120ng/ml recombinant CSF-1, was ﬁxed and stained for phosphoY118 paxillin (green) and F-actin (red). Phospho-
Y118paxillinstainingeliminatesbackgroundcytoplasmicstainingofunphosphorylatedpaxillin[1,16].Thearrowindicatesfocalcomplexes
at the leading edge and the arrowhead indicates a focal adhesion giving rise to a stress ﬁber. (b) MacCsf1r−/−. WT macrophage, grown on a
ﬁbronectin coated coverslip in α+MEM, 10% FCS, and 120ng/ml recombinant CSF-1, was ﬁxed and stained for phosphoY118 paxillin (red)
and F-actin (green) and examined by TIRF microscopy. The arrow indicates a focal complex giving rise to an F-actin cable. (c) Inverted
image of phosphoY118 paxillin IF staining at the leading edge of the primary ﬁbroblast, yellow circles indicate several nascent adhesions,
green ovals highlight focal complexes and red ovals outline some focal adhesions. (d) Inverted image of phospho-Y118 paxillin IF staining
in the leading lamellipodium of the macrophage, yellow circles indicate point contacts with strong phosphopaxillin staining, red circles
indicate point contacts with moderate phosphopaxillin staining and green ovals outline the linear focal complexes. (e) A larger view of
the ﬁbroblast stained for pY118 paxillin (left) and shown by phase contrast (right) to demonstrate the co-cultured primary macrophage
migrating underneath the ﬁbroblast (arrow) and disrupting its focal adhesions. Note the lack of macrophage focal adhesions. Scale bars =
10μM.
pattern of adhesion at the leading edges of ﬁbroblasts
(Figure 1(c)) and macrophages (Figure 1(d)).
3. Macrophage Adhesions
Adhesions are multiprotein complexes that not only struc-
turally link the cell adhesion receptors, integrins, to the actin
cytoskeleton but also integrate and regulate a range of signals
important for cell motility and growth [41]. The molecular
associations and movement of individual components in the
complexes are highly dynamic, allowing rapid responses to
environmental and cellular cues [28, 42]. Tyrosine phospho-
rylation is an important regulatory mechanism for dynamic
interplayofthesecomponents[43–45].Anumberoftyrosine
kinases localize to adhesions, including Src family kinases
(SFK) and the adhesion kinases, focal adhesion kinase (FAK)
andPyk2,wheretheyphosphorylate manyadhesion proteins4 International Journal of Cell Biology
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Figure 2: Macrophages form podosomes. (a) A human monocyte-derived macrophage, grown on a ﬁbronectin coated coverslip in RPMI,
10% FCS, and 120ng/ml of recombinant CSF-1, was ﬁxed and stained for F-actin (red) and pY118 paxillin (green). Inset in the merge
panel demonstrates the central F-actin-rich stud and the surrounding pY118 paxillin collar. (b) Cytoskeletal TEM preparation of a human
monocyte-derived macrophage, grown on a glass coverslip, demonstrating many podosomes at the presumed leading edge. The arrow
highlights a good example of a podosome containing a central dense actin column surrounded by radially orientated actin ﬁlament spokes.
(c) Mouse bone marrow-derived macrophages were plated on Alexa-488 labeled ﬁbronectin overlaying gelatin for 24 hours prior to ﬁxation,
staining for F-actin (red) and examination by confocal microscopy to demonstrate a podosomal rosette digesting the underlying matrix.
upon integrin engagement [41, 46]. Prominent among the
phosphorylated adhesion proteins are the kinases themselves
and paxillin, a highly phosphorylated multidomain scaﬀold
protein that integrates and coordinates the regulation of
adhesion signaling molecules, many of which control actin
polymerization and actomyosin contractility [47]. Indeed,
ﬂuorescently tagged paxillin has been widely used to exam-
ine adhesion formation in living and ﬁxed cells. Due to
their small size and extensive ventral surface distribution,
macrophage adhesion structures are diﬃcult to visualize, as
cytoplasmicpaxillinalmostcompletelyobscuresthem.How-
ever, paxillin translocates to the plasma membrane and to
adhesions when phosphorylated on Y31/Y118, so the use
of phosphospeciﬁc paxillin antibodies and total internal
reﬂection ﬂuorescence microscopy (TIRF) greatly enhances
ourcapacitytoexaminemacrophageadhesions(Figure 1(b))
[16, 25, 48]. Despite their lack of large, longer lived adhe-
sions, macrophages can be successfully cultured on glass and
bacterial plastic. Moreover, the combined adhesive capacity
of their collected point contacts and focal complexes enables
macrophages to push underneath cocultured ﬁbroblasts,
disrupting the ﬁbroblast’s focal contacts in the process
(Figure 1(e), arrow). Consistent with this observation, adhe-
sion strength is positively correlated withthe adhesive area of
a cell and leading edge focal complexes have been shown to
support a stronger traction force than mature focal contacts
[35, 49]. Thus, it appears that individually weak adhesions
in macrophages collectively give rise to robust but dynamic
adhesion and, in combination with a readily remodeled
actin cytoskeleton, permit rapidly responsive migration in
macrophages.
In addition to point contacts and focal complexes, ma-
crophages also form podosomes, which are short-lived adhe-
sion/motility organelles that consist of a dense core of actin
surrounded by a collar of adhesion proteins (Figure 2(a))
[50, 51]. Cytoskeletal transmission EM studies indicate that
podosomes have a distinctive hub and spoke microﬁlament
architecture (Figure 2(b),a r r o w )[ 52]. In contrast to focal
complexes, they are able to digest extracellular matrix and
so are thought to be important for interstitial migration of
macrophages and other myeloid cells [51, 53, 54]. It is not
clear how podosomes contribute to motility but individual,
short-lived podosomes often coalesce into higher order,
m o r es t a b l es t r u c t u r e ss u c ha sr o s e t t e st h a te ﬃciently digest
the underlying matrix (Figure 2(c))[ 55, 56]. Osteoclasts
form large podosomal arrays or belts within which separate
podosomes may become indistinct and which create the
sealing zone necessary for eﬀective bone resorption within
the perimeter of this gasket [52]. Podosomes may also be im-
portant for leukocyte diapedesis, either between or throughInternational Journal of Cell Biology 5
endothelial cells [57, 58]. Importantly, matrix digesting
actin-rich rosette-like structureshave been imaged in human
primary macrophages within a 3D gelled collagen matrix,
strongly suggesting podosomes play a role in macrophage
migration in vivo [33].
Comparedtoactin-richrosettes,imagingadhesionstruc-
tures in living cells in 3D culture is diﬃcult, leading to some
doubt that they exist in vivo. However, by lowering the ex-
pression levels of genetically encoded ﬂuorescently tagged
adhesion proteins to reduce background cytoplasmic ﬂuo-
rescence, dynamic paxillin-rich 1μM cell-matrix adhesions
wereobservedintheprotrusionsofU2OSosteosarcomacells
g r o w ni n3 Dc o l l a g e ng e l s[ 59]. These adhesions were dem-
onstrated to form in contact with collagen ﬁbers, suggesting
adhesions are likely to be found in vivo in mesenchymally
migratingcells.However,invivodetectionofadhesionstruc-
t u r e swi l lb ee x t r e m e l yd i ﬃcult, particularly in macrophages,
which form such small adhesions in 2D culture systems.
4. CSF-1Regulation of Macrophage Motility
Although CSF-1 was initially identiﬁed as a macrophage
growth and diﬀerentiation factor [5], it was subsequently
demonstrated to stimulate monocyte migration [14] and lat-
erstudiesconﬁrmedthatCSF-1isapotentchemokineticand
chemotactic factor for macrophages [15]. Indeed, the patho-
physiological importance of CSF-1-stimulated macrophage
migration has recently been demonstrated in several dis-
eases, including tumour invasion and metastasis [20, 60],
inﬂammatory arthritis [61–63] and atherosclerosis [64, 65].
Tumor-associated macrophages secrete epidermal growth
factor (EGF) and carcinoma cells secrete CSF-1 to set up a
paracrinechemotacticloopthatinducescomigrationofboth
cell types and promotion of invasion and metastasis [20,
59]. Inhibition of either EGF receptor or CSF-1R signaling
prevents tumour cell motility in vivo [20]. Synovial macro-
phages have long been known to play a critical role in chron-
ic rheumatoid arthritis and conventional therapies all reduce
macrophage numbers in the synovium [66]. CSF-1, which
is secreted by synoviocytes and endothelial cells, attracts
monocytes to arthritic joints and stimulates their diﬀeren-
tiation into inﬂammatory cytokine secreting macrophages
and bone resorbing osteoclasts [66]. Importantly, selective
CSF-1R inhibition signiﬁcantly reduced joint inﬁltration
and diﬀerentiation of macrophages in several autoimmune
arthritis models with subsequent improvement in arthritis
severity [63]. Downstream of the CSF-1R, a mutation caus-
ing reduced expression of PSTPIP2, a signaling protein that
is selectively expressed in macrophages, results in an autoin-
ﬂammatory disease [67, 68]. PSTPIP2 is tyrosine phoshory-
lated in response to CSF-1 and regulates ruﬄing, ﬁlopodia
formation, and CSF-1-induced motility [67]. Thus CSF-1
regulation of macrophage migration is important in the
development and progression of several diseases and elu-
cidation of CSF-1-stimulated motility pathways is likely to
identifypossibletherapeutictargetstomodulatemacrophage
inﬁltrative capacity.
5. CSF-1R Signalingto Macrophage Motility
CSF-1 initially triggers membrane ruﬄing and spreading
followed by increased formation of phosphotyrosine-rich
adhesions and ﬁnally the macrophages polarize and begin to
move [16, 40, 69]. CSF-1-stimulated actin polymerization is
very rapid, with a sharp peak at 30sec followed by a longer
lasting wave at 3min [69]. Polymerization is regulated by
Rho family GTPases, Rac, Rho, and Cdc42, whose eﬀectors
include the Wiskott Aldrich syndrome protein (WASP)/
WASP-family verprolin homologous (WAVE) family of actin
nucleators [70, 71]. Increased focal complex and point con-
tact formation is visible by 5 minutes but does not peak until
15min after CSF-1 stimulation, coincident with maximal
phosphorylation of paxillin by its adhesion kinases, Pyk2
and FAK [40]. Consistent with the importance of actin po-
lymerization and adhesion formation in macrophage migra-
tion, macrophages deﬁcient in Pyk2, FAK, WASP, or WAVE2
are poorly motile [48, 72–74]. However, the mechanisms by
which CSF-1 stimulates actin polymerization and adhesion
formation are not well understood and require careful dis-
section of the signaling pathways triggered by CSF-1R
activation.
The eﬀects of CSF-1 are mediated by the CSF-1R, a
RTK of the platelet derived growth factor receptor (PDGFR)
family. Upon binding of homodimeric CSF-1, the CSF-1R
dimerizes,becomesactivatedandautophosphorylatesatleast
7 of its 20 intracellular tyrosine residues [1]. Phosphory-
lation of these tyrosine residues creates speciﬁc binding
sitesforphosphotyrosine (pTyr)binding domain-containing
molecules and initiates a series of signaling cascades, leading
to rapid stimulation of cytoskeletal remodeling and adhesion
as well as gene transcription and protein translation [1, 75].
To identify pTyr CSF-1R-associated molecules and examine
the speciﬁc pathways that mediate the various eﬀects of
CSF-1, earlier studies either ectopically expressed wild-type
or tyrosine-to-phenylalanine (Y→F) mutant CSF-1Rs in
ﬁbroblasts or expressed chimeric receptors composed of a
non-CSF-1R extracellular domain and Y→Fm u t a t e dC S F -
1R intracellular domains in myeloid cells. Results diﬀered
between ﬁbroblast and myeloid cell studies, in part because
mature macrophages selectively express speciﬁc proteins,
isoforms or splice variants important for CSF-1R signaling
[1, 67, 76]. To overcome these problems, we developed a
system to express a single species of CSF-1R in a mature
macrophage context. Immortalised macrophages derived
from the CSF-1R−/− mouse were transduced with either a
wild-type or a tyrosine mutant CSF-1R [11, 77]. The Y-
Eight-F (YEF) mutant CSF-1R, with eight tyrosine residues
mutated to phenylalanine, is not phosphorylated in response
to CSF-1 and macrophages expressing this receptor cannot
survive in CSF-1 [77]. The system was used to examine loss-
of-function eﬀects of a panel of individual Y→F CSF-1R
molecules and we have shown that phosphorylation of Y706
and Y721 in the kinase insert and Y974 at the C-terminus of
the CSF-1R are important for normal macrophage morphol-
ogy while juxta-membrane Y559 and activation loop Y807
are critical for macrophage proliferation and diﬀerentiation
[77].TheYEFCSF-1Rcanbeusedasabackboneonwhichto6 International Journal of Cell Biology
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Figure 3: A schematic of signaling pathways activated by the Rho
GTPases in macrophages. Generic GEFs and GAPs aredesignated as
upstream regulators of Cdc42, Rac, and Rho activity. Downstream
signaling molecules speciﬁcally labeled in the schematic are those
that are described in the text. Signaling pathway outcomes are
depicted for actin cytoskeleton responses only. Regulation of
adhesion by Rho GTPases in macrophages is not shown as the
signaling pathways are not yet elucidated.
add-back individual tyrosine residues. Add-back to the YEF
CSF-1R of two known phosphotyrosine residues, Y559 and
Y807, and a third, Y544, that may not be phosphorylated
but is thought to be important for CSF-1R conformation,
restores full proliferation in response to CSF-1 (unpublished
results). Add-back of single tyrosine residues to the YEF
receptor has been used to demonstrate that Y559 is the ﬁrst
residue phosphorylated in response to CSF-1 [78] and that
it is necessary and suﬃcient for c-Cbl-mediated receptor
ubiquitylation, full activation, and subsequent degradation
of the receptor [78]. Individual tyrosine residues can also
be added back to minimal proliferation competent add-
back (AB) receptor, YEF. Y544, Y509, Y807 AB CSF-1R, to
examine return-of-functionsignaling fortheremaining pTyr
residues.
Macrophages elongate when they polarize and begin to
move [15, 79] so a loss of elongation can indicate reduced
motility[40,80].Cellsexpressing theY721Fmutantreceptor
were apolar and previous studies in other cell lines had
demonstrated a pY721-dependent association with the CSF-
1R of two proteins known to signal to cell motility, phos-
phoinositide 3-kinase (PI3K) and phospholipase C (PLC)γ2
[81–83]. A detailed examination of the Y721F CSF-1R
macrophages revealed a signiﬁcant reduction in motility in
vitro and, perhaps more importantly, these macrophages
moved less well in vivo and there was a signiﬁcant reduction
in their capacity to enhance tumour cell invasion in vitro
[69]. Underlying the reduction in motility was a loss of
the ﬁrst peak of CSF-1-stimulated actin polymerization and
reduced paxillin phosphorylation and incorporation into
adhesions. Add-back of Y721 to the YEF. Y544, Y559, Y807
AB CSF-1R restored actin polymerization and cell motil-
ity, indicating that pY721-based signaling regulates CSF-1-
induced macrophage motility [69]. This system was also
used to identify which of the two possible eﬀectors, PI3K or
PLCγ2, was responsible for initiating pY721-based motility
signaling. While PLCγ2 associated with the activated CSF-
1R in a pY721-independent manner, CSF-1 rapidly stim-
ulated a prolonged Y721-dependent association of PI3K
with the receptor, which resulted in PIP3 production [69].
Thus the primary mediator of CSF-1-stimulated motility in
macrophages is PI3K.
Class IA PI3Ks consist of a p110 catalytic subunit bound
to a p85 regulatory subunit that translocates to activated
RTKs upon interaction of its SH2 domains with pYXXM
motifs, including Y721VEM in the CSF-1R [69, 84]. Upon
binding, p85 activates p110 to produce phosphatidylinositol
3,4,5-trisphosphate(PIP3)fromPI4,5-bisphosphate(PIP2)
at the cell membrane [85]. An accumulation of PIP3 at the
leading edge stimulates migration by inducing plasma mem-
brane translocation of pleckstrin homology (PH) domain-
containing molecules, PDK1, Akt, and Rho family GTPase
regulators, or molecules with other PIP3 binding motifs
such as WASP and its homologues [86, 87]. RTK-induced
PIP3 levels are rapidly returned to baseline levels by the
phospholipid phosphatase, PTEN [84]. While p110α and β
are ubiquitously expressed, p110δ expression is highly en-
riched in hematopoietic cells, including macrophages. The
three PI3K p110 isoforms have nonredundant biological
roles and their function diﬀers between primary and immor-
talised macrophages such that while p110δ is the main iso-
form recruited to the CSF-1R in bone marrow-derived ma-
crophages,allthreearerecruited to thereceptor in BAC1.2F5
macrophages [84]. However, PI3K p110δ appears to be the
main regulator of migration in both primary macrophages
andBAC1.2F5cells,inwhichittriggersactinpolymerization,
cytoskeletal remodeling, and cell adhesion [84]. The exact
pathways by which induction of PIP3 mediates these dis-
parate eﬀects of CSF-1 stimulation have yet to be identiﬁed,
but regulation of individual elements further downstream in
macrophage migration are becoming clearer and appear to
converge on the Rho family GTPases.
6. Rho FamilyGTPasesinMacrophage Motility
Rho family GTPases are well-known regulators of actin po-
lymerizationandcelladhesiondownstreamofRTKsinmany
diﬀerentcelltypes [88]. Themain Rhofamilyproteins found
in macrophages are RhoA, RhoB, Rac1, Rac2, and Cdc42
[70]. Rho GTPases are activated by guanine-nucleotide ex-
change factors (GEFs), which stimulate the exchange of
GDP for GTP, and inactivated by GTPase activating proteins
(GAPs), which stimulate GTP hydrolysis (Figure 3). Upon
activation, Rho family GTPases interact with eﬀector pro-
teins, including actin polymerization activators and protein
kinases. Selective expression of GEFs, GAPs, and eﬀectorInternational Journal of Cell Biology 7
proteins plus spatiotemporal regulation of activation and
regulatory crosstalk between Rho family proteins results
in highly complex and dynamic coordination of cytoskele-
tal remodeling in response to RTK stimulation [88, 89].
Fluorescence resonance energy transfer (FRET) biosensors
have been used to demonstrate in real time that the three
ubiquitously expressed Rho family proteins, RhoA, Rac1,
and Cdc42, are all activated at the leading edge of cells
with very small diﬀerences in time and space [90, 91]. Rho
family biosensors have yet to be used in CSF-1-dependent
macrophage cell lines, which are diﬃcult to transfect, but
recent use of a WASP biosensor in RAW264.7/L5 macro-
phages demonstrated Cdc42-dependent activation of WASP
in CSF-1-induced protrusions [92]. Early research into the
role of Rho family proteins in macrophages used microin-
jection of constitutively active or dominant negative RhoA,
Rac1, or Cdc42 to show that Cdc42 promoted ﬁlopodia
formation while Rac stimulated ruﬄing and lamellipodial
spreading and Rho triggered actomyosin contractility and
retraction of the trailing edge in response to CSF-1 [93]. In
addition,RacandCdc42stimulatedfocalcomplexformation
[94]. A subsequent study indicated that Rac and Rho were
important for macrophage migration while Cdc42 regulated
polarization and chemotactic sensing [94]. However, dom-
inant negative proteins, particularly when overexpressed,
may not be speciﬁc for their GEFs, and conditional knock-
out and knock-down approaches have been used more
recently to examine the role of Rho family proteins in
macrophage actin remodeling and motility [70]. Although
little is known about the loss of Cdc42 function, the eﬀects
of deletion of Rac1, which is ubiquitously expressed, and
the hematopoietically restricted Rac2 have been reported
[95–97]. Surprisingly, loss of both Rac1 and Rac2 did not
decrease CSF-1-induced 2D motility, although Rac1/2−/−
macrophages did not form ruﬄes, normal lamellipodia, or
podosomes [97]. Moreover, loss of Rac1 reduced invasive
capacity of macrophages in Matrigel while loss of Rac2
reduced peritoneal macrophage inﬁltration in response to an
inﬂammatory stimulus, suggesting both Rac proteins may be
important for macrophage interstitial migration in vivo [96,
97]. In contrast to the unexpectedly mild loss-of-function
phenotype of Rac1/2, C3 transferase-induced inhibition of
RhoA-C inhibited CSF-1-stimulated macrophage migration
and actomyosin contractility [40, 94]. Interestingly, global
activation of Rac, Rho, or Cdc42 is not detected in CSF-
1 stimulated macrophages at the time of the ﬁrst wave of
actin polymerization, suggesting local changes may be subtle
[69]. Thus, the complexities and redundancies of Rho family
GTPase signaling makes it diﬃcult to tease apart the ﬁner
aspects of their role in CSF-1-induced motility. Production
and examination of Cdc42−/− and RhoA−/− macrophages as
well as FRET studies should prove illuminating. Neverthe-
less, further mechanistic insights into Rho family GTPase
regulation of macrophage motility have been gained through
examination of their main downstream eﬀectors for actin
polymerization, the WASP and WAVE complexes [71, 98].
Inmacrophages,Cdc42andRacstimulateactinpolymer-
ization by activating the Arp2/3 complex through their GTP-
dependent association with the Arp2/3 activating scaﬀold
proteins, WASP and WAVE, respectively [98, 99]. WASP
was originally discovered as the hematopoietically expressed
product of the gene mutated in the X-linked immuno-
logical disorder Wiskott Aldrich Syndrome (WAS) and is
an important downstream eﬀector of Cdc42 [92, 98, 99].
WAS myeloid cells display marked cytoskeletal abnormalities
and cannot form podosomes, and WAS macrophages fail to
chemotax towards CSF-1 [53, 73, 99]. WASP does not act in
isolation and requires its N-terminal binding protein, WASP
interacting protein (WIP), to form a functional unit that
activates Arp2/3 in podosome formation and transendothe-
lial migration in macrophages [99, 100]. Consistent with the
requirement for both proteins to activate Arp2/3, WIP−/−
dendritic cells also fail to form podosomes, instead forming
longer lived focal contacts [101]. The WAVE family proteins,
WAVE1, 2, and 3, each stably complex with several other
proteins in order to mediate the eﬀects of Rac [71, 98].
WAVE2, which is the major WAVE isoform expressed in
macrophages, is important for CSF-1 stimulation of ruﬄing
and migration [74]. Thus, both WASP and WAVE2 activate
the Arp2/3 complex to stimulate dendritic or branched actin
polymerization, but WASP mediates regulation of chemo-
taxis by Cdc42, while WAVE2 mediates the regulation of
ruﬄing and motility by Rac. Rather than activating Arp2/3,
Rho promotes actomyosin contractility through activation
ofRho-kinase(ROCK)1andROCK2.Unexpectedlyhowever,
ROCK1−/− macrophages were more motile towards CSF-1
in vitro and responded to an inﬂammatory stimulus more
readily in vivo [102]. Underlying their increased migration,
ROCK1−/− macrophages demonstrated increased adhesion
on ﬁbronectin and increased CSF-1-stimulated F-actin levels
in association with increased PIP3 levels. ROCK1 was shown
to negatively regulate CSF-1-induced migration through
regulation of PTEN activity [102]. Rho also mediates its
eﬀects through activation of the formin family of actin
nucleators, which assemble linear rather than branched actin
ﬁlaments, but their role in macrophage motility is currently
unknown [103].
ThespeciﬁcrolesofindividualRhofamilyproteinsinthe
regulation of macrophage adhesion is less well understood
than their roles in actin polymerization and actomyosin con-
tractility and is made more complex by the fact that there is
crosstalkbetween actin polymerization, actomyosin contrac-
tility, and adhesion formation and turnover [37, 104]. Nev-
ertheless,CSF-1stimulatestheincorporationoftheadhesion
kinases, FAK and Pyk2, and their substrate, paxillin, into
focal complexes and point contacts a few minutes after it
stimulates actin polymerization, ruﬄing, and spreading in
macrophages[40,48,69].FAKisknowntoregulateadhesion
formation and disassembly and both FAK and Pyk2 regulate
macrophagemigrationinvitroandinvivo,apparentlyviathe
same pathway, as loss of Pyk2 does not further reduce migra-
tion and invasion in FAK−/− macrophages [48, 72]. The
precisemechanismbywhichCSF-1RsignalingactivatesPyk2
and FAK to regulate adhesion formation and turnover is
not understood but CSF-1-stimulated FAK−/− macrophages
demonstrated high levels of Rac activity in association
with hyperprotrusiveness [48] while Pyk2−/− macrophages
showed reduced integrin-mediated Rho activation [72].8 International Journal of Cell Biology
These suggestions that adhesion signaling feeds back on
actin polymerization and actomyosin contractility are not
unexpectedasmanyRhofamilyGEFsandGAPsarerecruited
to adhesions where they can activate or inhibit Rho family
proteins [41]. Moreover, activated and autophosphorylated
FAK and Pyk2 associate with SFKs in adhesions, facilitating
SFK-based phosphorylation and regulation of nearby Rho
family GEFs and GAPs as well as other adhesion proteins
[104]. Phosphorylation of paxillin triggers its translocation
to adhesions and brings along associated Rac eﬀectors
that are critical for leading edge formation and adhesion
turnover [43, 47]. Thus, adhesions themselves are important
platformsfortheregulation ofRhofamilyproteins [37,104].
An area where the role of individual Rho GTPases has
been more clearly deﬁned in macrophages is phagocytosis,
which is a highly ordered process of membrane protrusion
and actin polymerization that uses many of the same ele-
ments of cellular machinery as locomotion [105]. FRET
studies of Fcγ receptor-mediated phagocytosis in RAW264.7
macrophages reveal distinct spatiotemporally regulated pat-
terns of Rac1, Rac2, and Cdc42 activation underlying actin
polymerization in the phagocytic cup [106]. In addition,
RhoG, which is more closely related to Rac than to Rho
[107], is recruited to phagocytic cups in J774 macrophages
[108]. Rho GTPases activate many of the same downstream
eﬀectors in phagocytosis as they do in motility, with both
WASP and Arp2/3 being required for normal Fcγ receptor-
mediated phagocytosis in macrophages [105]. Further re-
ﬁnements in the application of FRET to CSF-1-dependent
maturemacrophageswillrevealthespeciﬁcspatiotemporally
regulated roles of individual Rho GTPases in adhesion,
motility, and phagocytosis.
7. Concluding Remarks
It is clear that the interplay between the diﬀerent elements
of the adhesion and motility apparatus, coordinated in large
part by Rho family GTPases, is complex and will require
the use of many diﬀerent approaches to unpack these com-
plexities. Mature macrophages have proven diﬃcult to adapt
to some approaches as, not only do they selectively express a
number of important adhesion and motility proteins but
they are diﬃcult to transfect [1]. Nevertheless, motile ma-
crophages contribute to the progression of a number of
important diseases and elucidation of how CSF-1 regulates
polarization, protrusion, adhesion, actomyosin contractil-
ity, and trailing edge retraction to stimulate migration is
important in the development of therapies to treat these
diseases. The CSF-1R-deﬁcient mouse macrophage cell line
(MacCsf1r−/−), when transduced with individual wild-type
or tyrosine mutant CSF-1Rs, allows examination of speciﬁc
signaling pathways triggered by individual tyrosine residues
in mature macrophages [77]. Using this system, Y721
was recently identiﬁed as the major CSF-1R phosphotyro-
sine residue triggering ruﬄing, adhesion, and motility in
response to CSF-1 [69]. Furthermore, the primary mediator
of pY721-based signaling to motility was demonstrated to be
PI3K[69],andworkisnowfocusedinidentifyingthespeciﬁc
PI3K p110 isoform and PI3K-activated pathways that regu-
late actin polymerization, adhesion formation, and migra-
tion in macrophages. CSF-1R and isoform speciﬁc PI3K
inhibitorsareavailableandmayproveusefulinthetreatment
of disseminated tumors and chronic inﬂammatory arthri-
tides.
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